During the second quarter of 2025, the apixaban price trend in the USA climbed to 44,617 USD/MT in June. The upward momentum reflected sustained demand for anticoagulant therapies, particularly for cardiovascular care, reinforcing firm market fundamentals and stable distribution channels. https://www.imarcgroup.com/apixaban-pricing-report